CS
Christopher Sarchi (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Replimune Group, Inc. (REPL). The largest single filing was $111K of REPL (12,000 sh × $9.24, as filed), executed Jun 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$111K
shares × price, as filed
Last traded
Jun 1
Filed Jun 3
Median ADV $90.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $111K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
REPLRecent filings
REPLSALE
Replimune Group, Inc.
View filing →
$111K12,000 sh × $9.24
Exec Jun 1
Filed Jun 3 · 5:30 PM ET